Alpha 2.0
Login Register
» Authors » Steven N Wolff

Steven N Wolff

Explore the profile of Steven N Wolff including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 143
Followers 0
Related Specialty
Oncology
Top 10 Co-Authors
Hillard M Lazarus
Julie Vose
Richard I Fisher
Myron Czuczman
Theresa Hahn
Kevin P Weinfurt
Worta McCaskill-Stevens
David D Hurd
Geoffrey P Herzig
Philip L McCarthy
Published In
J Clin Oncol
Biol Blood Marrow Transplant
J Oncol Pract
J Health Care Poor Underserved
Affiliations
Soon will be listed here.
Recent Articles
1.
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations
Denicoff A, McCaskill-Stevens W, Grubbs S, Bruinooge S, Comis R, Devine P, et al.
J Oncol Pract . 2013 Oct; 9(6):267-76. PMID: 24130252
Introduction: Many challenges to clinical trial accrual exist, resulting in studies with inadequate enrollment and potentially delaying answers to important scientific and clinical questions. Methods: The National Cancer Institute (NCI)...
2.
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review
Oliansky D, Czuczman M, Fisher R, Irwin F, Lazarus H, Omel J, et al.
Biol Blood Marrow Transplant . 2010 Jul; 17(1):20-47.e30. PMID: 20656046
Clinical research published since the 2001 evidence-based review on the role of hematopoietic stem cell transplantation (SCT) in the treatment of diffuse large B cell lymphoma (DLBCL) in adults is...
3.
Applying sensitivity analyses to overall survival in cancer clinical trials
Wolff S
J Clin Oncol . 2010 Jun; 28(19):e323. PMID: 20516448
No abstract available.
4.
Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource
Wujcik D, Wolff S
J Health Care Poor Underserved . 2010 Feb; 21(1 Suppl):38-50. PMID: 20173284
In 2000, using National Institutes of Health/National Cancer Institute (NIH/NCI) U54 funds, a clinical trials shared resource was established at Nashville General Hospital at Meharry to attract more African Americans...
5.
High-dose etoposide: from phase I to a component of curative therapy
Wolff S, Hainsworth J, Greco F
J Clin Oncol . 2008 Oct; 26(33):5310-2. PMID: 18838698
No abstract available.
6.
High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later
Lazarus H, Phillips G, Herzig R, Hurd D, Wolff S, Herzig G
J Clin Oncol . 2008 May; 26(14):2240-3. PMID: 18467711
No abstract available.
7.
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma
Hahn T, Wolff S, Czuczman M, Fisher R, Lazarus H, McCarthy P, et al.
Biol Blood Marrow Transplant . 2003 Oct; 9(10):667. PMID: 14569563
No abstract available.